Sector consensus Bristol-Myers Squibb Company

Stocks

Market Closed - NYSE Other stock markets 21:00:02 15/07/2026 BST			5-day change	1st Jan Change
58.72 ^USD	+3.11%		+2.05%	+8.86%

07-13	Bristol Myers Squibb Receives FDA Acceptance for New Drug Application For Mezigdomide in Combination with Carfilzomib and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma	CI
07-13	Bristol Myers Wins FDA Review of Mezigdomide in Multiple Myeloma	DJ

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Objective/dr gap	Nbr of analysts
BRISTOL-MYERS SQUIBB COMPANY	62.96	+7.22%	24
ELI LILLY AND COMPANY	1,270.37	+9.83%	27
JOHNSON & JOHNSON	265.64	+7.54%	22
ABBVIE INC.	266.57	+9.2%	28
ROCHE HOLDING AG	359.22	+8.79%	18
NOVARTIS AG	153.17	+1.26%	21
ASTRAZENECA PLC	212.83	+25.57%	22
NOVO NORDISK A/S	316.91	-4.13%	24
AMGEN INC.	356.62	-0.47%	29
GILEAD SCIENCES, INC.	158.3	+20.19%	27
PFIZER INC.	28.79	+15.98%	26
VERTEX PHARMACEUTICALS INCORPORATED	556.96	+16.74%	25
SANOFI	96.31	+26.3%	23
GSK PLC	21.2	+10.62%	19
CHUGAI PHARMACEUTICAL CO., LTD.	9,853.33	+38.23%	15
BAYER AG	54.92	+15.11%	18
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	80.52	+40.04%	15
TAKEDA PHARMACEUTICAL COMPANY LIMITED	6,106.87	+15.49%	15
HALEON PLC	4.142	+15.32%	17
Average	1,064.51	+14.67%	22
Weighted average by Cap.	707.32	+10.77%	24